- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
DHS more than doubles revenue
Imaging services provider Diagnostic Health Services of Dallas reported that it enjoyed revenue growth for 1997 (end-December) that was 119% higher than sales in 1996. DHS recorded sales of $59.9 million in 1997, compared with $24.2 million the year
Imaging services provider Diagnostic Health Services of Dallas reported that it enjoyed revenue growth for 1997 (end-December) that was 119% higher than sales in 1996. DHS recorded sales of $59.9 million in 1997, compared with $24.2 million the year before. Net income also grew sharply, to $5.4 million, compared with $2.5 million in 1996.
DHS experienced strong internal growth in 1997, and also completed seven acquisitions during the year, according to chairman and CEO Max Batzer. The firm has continued on its acquisition bent in the first quarter of 1998, buying two companies and signing an agreement to acquire a 50% interest in a California imaging center. The two acquisitions were International Cardiac Monitoring, a Houston-based cardiac event monitoring business, and Sonomed, a mobile ultrasound provider based in Birmingham, AL. The California imaging center is on the campus of Scripps Hospital in Chula Vista, and buying the joint interest will broaden Diagnostic Health's hospital-based MRI operations.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
